Navigation Links
Millions Around the World to Have Access to Low-Cost HIV Test by 2013
Date:6/20/2012

MELBOURNE, Australia, June 20, 2012 /PRNewswire/ -- For the first time, HIV patients in developing countries will have access to an affordable diagnostic test to determine if they should start life-saving antiretroviral drugs.

The Burnet Institute in Melbourne has announced a licensing agreement with Omega Diagnostics Group PLC, a global diagnostics organisation, to commercialise the point-of-care CD4 test for use worldwide, including aid agencies delivering frontline health services.

Omega has manufactured a first small-scale batch of prototype devices but reports there is still further work to do in terms of manufacturing scale-up and field trial evaluations before the first commercial sale of product. The company will host the commercial launch of the POC CD4 test at the 19th International AIDS Conference, AIDS 2012, to be held in Washington DC from 22-27 July.

Burnet Institute Deputy Director, Associate Professor David Anderson developed the low-cost test along with Co-head of Burnet's Centre for Virology Professor Suzanne Crowe AM.

"According to UNAIDS, there are 15 million people who should be getting access to antiretroviral therapy but aren't, just because they can't get access to an affordable CD4 test in their communities," Associate Professor Anderson said.

The CD4 test uses a small amount of blood from a finger-prick with results available after 40 minutes at a cost significantly less than the existing tests.

Current tests to determine CD4 cell count cost more than AUD $10. It requires trained health workers to collect venous blood and highly trained technicians to perform the tests on expensive equipment requiring power, clean water and regular maintenance.

"It's easy to diagnose HIV but it's hard to identify those who need therapy, this test will change that, providing cost effective testing for up to 33 million patients worldwide," Professor Anderson said.

Aid agencies in Papua New Guinea, India and South Africa are likely to be among the first to access the Burnet CD4 test.

This is the culmination of six years work by Associate Professor Anderson, Professor Crowe AM, Mary Garcia, Nadine Barnes, Simone Van de Waarsenburg, Jocelyn Diaz, Robyn Lloyd and Joy Liu at Burnet. It was also developed in collaboration with Professor Alan Landay from Rush University in Chicago and Professor Thomas Denny from Duke University in North Carolina.

To arrange an interview with Associate Professor David Anderson please contact:
Catherine Somerville
Media and Communications Officer, Burnet Institute
Ph: +61 422 043 498 or email: cathsomerville@burnet.edu.au  


'/>"/>
SOURCE Burnet Institute
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
2. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
3. Ophthalmic Drugs: World Market Prospects 2012-2022
4. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
5. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
6. Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
7. Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
8. Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012
9. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
10. Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel
11. DebMed® to Debut Benefits of Worlds First Electronic Hand Hygiene Compliance Monitoring System Using the WHO Five Moments at Annual Infection Control Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... N.J. , April 28, 2016   Acsis ... today announced that leading IT market research and advisory ... " in the IDC MarketScape: Worldwide Pharmaceutical Track and ... 2016).  The report provides an assessment of the capabilities ... track and trace software market. Logo - ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
Breaking Medicine Technology:
(Date:4/29/2016)... STAMFORD, CONNECTICUT (PRWEB) , ... April 29, 2016 , ... ... 5K Run/Walk” at Cove Island Park on Sunday, with sunny skies, a light breeze ... event, raising nearly $33,000. , The 5k Run and Walk and 1-mile ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... announced that student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 ... the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee Award ...
(Date:4/29/2016)... ... ... is the deadliest type of skin cancer. Although only about 1 percent of skin cancer ... than 10,000 people are expected to die of melanoma this year. The risk increases with ... the most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may ...
(Date:4/29/2016)... ... , ... For those who skip meals occasionally (which is pretty much everyone), ... many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of ... show. Bonny and Lawrence noted that because proper nutrition, including water, provides energy during ...
(Date:4/29/2016)... N.J. (PRWEB) , ... April 29, 2016 , ... ... digital and print media enterprise focused entirely on patients with cancer, today announced ... California, was chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing ...
Breaking Medicine News(10 mins):